Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1175.55
-10.90 (-0.92%)
< Home < Back

Dr. Reddy's Laboratories reports 12% rise in Q2 consolidated net profit

Date: 29-10-2022

Dr. Reddy's Laboratories has reported results for second quarter ended September 30, 2022.

The company has reported 2- fold jump in its net profit at Rs 1116.30 crore for the quarter under review as compared to Rs 449.00 crore for the same quarter in the previous year. Total income of the company increased by 26.81% at Rs 4998.30 crore for Q2FY23 as compared Rs 3941.50 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported rise of 11.89% in its net profit at Rs 1114.20 crore for the quarter under review as compared to Rs 995.80 crore for the same quarter in the previous year. Total income of the company increased by 6.34% at Rs 6372.60 crore for Q2FY23 as compared Rs 5992.40 crore for the corresponding quarter previous year.